About Eargo
Eargo is a company based in San Jose (United States) founded in 2010 by Florent Michel. Eargo has raised $216.58 million across 7 funding rounds from investors including SQ Capital, NEA and Charles and Helen Schwab Foundation. The company has 45 employees as of December 31, 2022. Eargo operates in a competitive market with competitors including Amplifon, Starkey, Audicus, IntriCon and InSound Medical, among others.
- Headquarter San Jose, United States
- Employees 45 as on 31 Dec, 2022
- Founders Florent Michel
- Stage Public
-
Sectors
HealthcareRetail Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$216.58 M (USD)
in 7 rounds
-
Latest Funding Round
$125 M (USD), Post-IPO
Jun 27, 2022
-
Investors
SQ Capital
& 10 more
-
Employee Count
45
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Eargo
Unlock access to complete
Funding Insights of Eargo
Eargo has successfully raised a total of $216.58M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $125 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Eargo
Eargo has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include SQ Capital, NEA and Charles and Helen Schwab Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Venture capital investments in consumer businesses, emphasizing technology and human behavior.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital firm investing in life sciences sector
|
Locked | Locked | Locked |
Investor details for Eargo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eargo
Investment portfolio details for Eargo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eargo
Detailed financials for Eargo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eargo Comparisons
Peer comparison for Eargo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eargo
Eargo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amplifon, Starkey, Audicus, IntriCon and InSound Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hearing aids and accessories are manufactured, distributed, and retailed.
|
|
| Locked | Locked | Locked |
Developer and manufacturer of hearing aids
|
|
| Locked | Locked | Locked |
Hearing aids are manufactured and sold online at reduced prices.
|
|
| Locked | Locked | Locked |
Miniature hearing aids and biomedical solutions are developed by IntriCon.
|
|
| Locked | Locked | Locked |
Extended-wear, invisible in-ear hearing systems were developed and marketed.
|
Detailed competitors of Eargo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eargo
Complete news archive for Eargo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eargo
Eargo was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Eargo is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Christian Gormsen is the current CEO of Eargo.
Eargo is a funded company, having raised a total of $216.58M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Eargo is 45.
Eargo was founded in 2010 in San Jose, United States, focusing on the hearing aid sector. Rechargeable devices that fit entirely inside the ear are offered, constructed using Flexi fiber and soft medical-grade silicon to suspend a small speaker. A mobile app is provided for adjusting settings across various listening environments. Products such as Eargo Neo and Eargo Max form part of the range.
Eargo has 11 investors. Key investors include SQ Capital, NEA, Charles and Helen Schwab Foundation, Maveron, and Nan Fung Life Sciences.